© Drug Hunter Inc. 2018-2023
Home > “compound 34”
oral PARP1-selective polymerase inhibitor
oral efficacy in BRCA1 mutant xenograft
from scaffold hopping from lit. PARP1/2 inh.
Bioorg. Med. Chem., Oct. 6, 2020
Lupin Ltd., Pune, IN
“compound 34” (Lupid oral in vivo PARP1-selective polymerase inhibitor)
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year